The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in Australia and Europe, and outlines their strategy to maintain market share and expand in emerging European markets.

lgp by the numbers
More From The Market Online

BPM Minerals granted Bonnie and Clyde drilling approvals

BPM Minerals has received the final key approval allowing for the maiden Bonnie & Clyde drilling…

Emperor signs contract rig for critical Judith-2 gas appraisal well

Emperor Energy is aiming to drill an appraisal well on Judith, the largest undeveloped conventional gas…

Omega Oil & Gas kicks off key new Taroom Trough well at Canyon-4

Omega Oil & Gas has kicked off the next key well aimed at confirming the world-class…
The Market Online Video

Market Open: Oil shock puts inflation and rates back in focus

Brent crude has surged above US$107 a barrel as escalating Middle East tensions raise fresh concerns…